LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. TI=CRISPR Based Diagnosis of Infectious and Noninfectious Diseases
  2. AU="Viswanathan, Aarthi"

Suchergebnis

Treffer 1 - 10 von insgesamt 10

Suchoptionen

  1. Artikel: CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases.

    Jolany Vangah, Somayeh / Katalani, Camellia / Booneh, Hannah A / Hajizade, Abbas / Sijercic, Adna / Ahmadian, Gholamreza

    Biological procedures online

    2020  Band 22, Seite(n) 22

    Abstract: ... relevant applications is in diagnosis of infectious and non-infectious diseases. Since its initial ... Cas13 enzyme). Viral, bacterial, and non-infectious diseases such as cancer can all be diagnosed using ... While the application of CRISPR in human genome editing and diagnosis needs to be researched more fully, and ...

    Abstract Interest in CRISPR technology, an instrumental component of prokaryotic adaptive immunity which enables prokaryotes to detect any foreign DNA and then destroy it, has gained popularity among members of the scientific community. This is due to CRISPR's remarkable gene editing and cleaving abilities. While the application of CRISPR in human genome editing and diagnosis needs to be researched more fully, and any potential side effects or ambiguities resolved, CRISPR has already shown its capacity in an astonishing variety of applications related to genome editing and genetic engineering. One of its most currently relevant applications is in diagnosis of infectious and non-infectious diseases. Since its initial discovery, 6 types and 22 subtypes of CRISPR systems have been discovered and explored. Diagnostic CRISPR systems are most often derived from types II, V, and VI. Different types of CRISPR-Cas systems which have been identified in different microorganisms can target DNA (e.g. Cas9 and Cas12 enzymes) or RNA (e.g. Cas13 enzyme). Viral, bacterial, and non-infectious diseases such as cancer can all be diagnosed using the cleavage activity of CRISPR enzymes from the aforementioned types. Diagnostic tests using Cas12 and Cas13 enzymes have already been developed for detection of the emerging SARS-CoV-2 virus. Additionally, CRISPR diagnostic tests can be performed using simple reagents and paper-based lateral flow assays, which can potentially reduce laboratory and patient costs significantly. In this review, the classification of CRISPR-Cas systems as well as the basis of the CRISPR/Cas mechanisms of action will be presented. The application of these systems in medical diagnostics with emphasis on the diagnosis of COVID-19 will be discussed.
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-09-14
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2027823-8
    ISSN 1480-9222
    ISSN 1480-9222
    DOI 10.1186/s12575-020-00135-3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel: Correction to: CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases.

    Vangah, Somayeh Jolany / Katalani, Camellia / Boone, Hannah A / Hajizade, Abbas / Sijercic, Adna / Ahmadian, Gholamreza

    Biological procedures online

    2020  Band 22, Heft 1, Seite(n) 24

    Abstract: An amendment to this paper has been published and can be accessed via the original article. ...

    Abstract An amendment to this paper has been published and can be accessed via the original article.
    Sprache Englisch
    Erscheinungsdatum 2020-11-07
    Erscheinungsland England
    Dokumenttyp Published Erratum
    ZDB-ID 2027823-8
    ISSN 1480-9222
    ISSN 1480-9222
    DOI 10.1186/s12575-020-00136-2
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases

    Jolany vangah, Somayeh / Katalani, Camellia / Booneh, Hannah A. / Hajizade, Abbas / Sijercic, Adna / Ahmadian, Gholamreza

    Biological Procedures Online

    2020  Band 22, Heft 1

    Abstract: ... relevant applications is in diagnosis of infectious and non-infectious diseases. Since its initial ... Cas13 enzyme). Viral, bacterial, and non-infectious diseases such as cancer can all be diagnosed using ... While the application of CRISPR in human genome editing and diagnosis needs to be researched more fully, and ...

    Abstract Abstract Interest in CRISPR technology, an instrumental component of prokaryotic adaptive immunity which enables prokaryotes to detect any foreign DNA and then destroy it, has gained popularity among members of the scientific community. This is due to CRISPR’s remarkable gene editing and cleaving abilities. While the application of CRISPR in human genome editing and diagnosis needs to be researched more fully, and any potential side effects or ambiguities resolved, CRISPR has already shown its capacity in an astonishing variety of applications related to genome editing and genetic engineering. One of its most currently relevant applications is in diagnosis of infectious and non-infectious diseases. Since its initial discovery, 6 types and 22 subtypes of CRISPR systems have been discovered and explored. Diagnostic CRISPR systems are most often derived from types II, V, and VI. Different types of CRISPR-Cas systems which have been identified in different microorganisms can target DNA (e.g. Cas9 and Cas12 enzymes) or RNA (e.g. Cas13 enzyme). Viral, bacterial, and non-infectious diseases such as cancer can all be diagnosed using the cleavage activity of CRISPR enzymes from the aforementioned types. Diagnostic tests using Cas12 and Cas13 enzymes have already been developed for detection of the emerging SARS-CoV-2 virus. Additionally, CRISPR diagnostic tests can be performed using simple reagents and paper-based lateral flow assays, which can potentially reduce laboratory and patient costs significantly. In this review, the classification of CRISPR-Cas systems as well as the basis of the CRISPR/Cas mechanisms of action will be presented. The application of these systems in medical diagnostics with emphasis on the diagnosis of COVID-19 will be discussed.
    Schlagwörter General Biochemistry, Genetics and Molecular Biology ; covid19
    Sprache Englisch
    Verlag Springer Science and Business Media LLC
    Erscheinungsland us
    Dokumenttyp Artikel ; Online
    ZDB-ID 2027823-8
    ISSN 1480-9222
    ISSN 1480-9222
    DOI 10.1186/s12575-020-00135-3
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases

    Somayeh Jolany vangah / Camellia Katalani / Hannah A. Booneh / Abbas Hajizade / Adna Sijercic / Gholamreza Ahmadian

    Biological Procedures Online, Vol 22, Iss 1, Pp 1-

    2020  Band 14

    Abstract: ... relevant applications is in diagnosis of infectious and non-infectious diseases. Since its initial ... Cas13 enzyme). Viral, bacterial, and non-infectious diseases such as cancer can all be diagnosed using ... While the application of CRISPR in human genome editing and diagnosis needs to be researched more fully, and ...

    Abstract Abstract Interest in CRISPR technology, an instrumental component of prokaryotic adaptive immunity which enables prokaryotes to detect any foreign DNA and then destroy it, has gained popularity among members of the scientific community. This is due to CRISPR’s remarkable gene editing and cleaving abilities. While the application of CRISPR in human genome editing and diagnosis needs to be researched more fully, and any potential side effects or ambiguities resolved, CRISPR has already shown its capacity in an astonishing variety of applications related to genome editing and genetic engineering. One of its most currently relevant applications is in diagnosis of infectious and non-infectious diseases. Since its initial discovery, 6 types and 22 subtypes of CRISPR systems have been discovered and explored. Diagnostic CRISPR systems are most often derived from types II, V, and VI. Different types of CRISPR-Cas systems which have been identified in different microorganisms can target DNA (e.g. Cas9 and Cas12 enzymes) or RNA (e.g. Cas13 enzyme). Viral, bacterial, and non-infectious diseases such as cancer can all be diagnosed using the cleavage activity of CRISPR enzymes from the aforementioned types. Diagnostic tests using Cas12 and Cas13 enzymes have already been developed for detection of the emerging SARS-CoV-2 virus. Additionally, CRISPR diagnostic tests can be performed using simple reagents and paper-based lateral flow assays, which can potentially reduce laboratory and patient costs significantly. In this review, the classification of CRISPR-Cas systems as well as the basis of the CRISPR/Cas mechanisms of action will be presented. The application of these systems in medical diagnostics with emphasis on the diagnosis of COVID-19 will be discussed.
    Schlagwörter CRISPR-Cas ; COVID-19 ; Diagnostic test ; SHERLOCK ; DETECTR ; Single guide RNA (sgRNA) ; Medicine (General) ; R5-920 ; Biology (General) ; QH301-705.5
    Thema/Rubrik (Code) 610
    Sprache Englisch
    Erscheinungsdatum 2020-09-01T00:00:00Z
    Verlag BMC
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: A novel detection method based on MIRA-CRISPR/Cas13a-LFD targeting the repeated DNA sequence of Trichomonas vaginalis.

    Yang, Zhenke / Wang, Jinghui / Qi, Yiming / Shi, Yiping / Li, Fakun / Wang, Weijuan / Tian, Xiaowei / Mei, Xuefang / Zhang, Zhenchao / Wang, Shuai

    Parasites & vectors

    2024  Band 17, Heft 1, Seite(n) 14

    Abstract: ... This method has the potential to enhance the diagnosis and management of vaginitis, offering a significant ... complications, including pelvic inflammatory disease, adverse pregnancy outcomes, and an increased risk ... of acquiring HIV. Current molecular detection methods for T. vaginalis are often costly and technically ...

    Abstract Background: Trichomonas vaginalis is a protozoan parasite, widely recognized as the most prevalent non-viral sexually transmitted infection (STI) globally. This infection is linked to various complications, including pelvic inflammatory disease, adverse pregnancy outcomes, and an increased risk of acquiring HIV. Current molecular detection methods for T. vaginalis are often costly and technically challenging.
    Methods: We developed a novel detection method for T. vaginalis using a multi-enzyme isothermal rapid amplification-clustered regularly interspaced short palindromic repeats (MIRA-CRISPR)/Cas13a-lateral flow device (LFD). This assay targets the repeated DNA sequence (GenBank: L23861.1) of T. vaginalis and is performed at a constant temperature of 37 °C for approximately 1 hour.
    Results: The detection limit of genomic DNA (gDNA) using our protocol was 1 × 10
    Conclusions: The MIRA-CRISPR/Cas13a-LFD method is a convenient, rapid, stable, and accurate diagnostic tool for detecting T. vaginalis. This method has the potential to enhance the diagnosis and management of vaginitis, offering a significant improvement over existing diagnostic techniques.
    Mesh-Begriff(e) Animals ; Female ; Pregnancy ; Base Sequence ; Trichomonas vaginalis/genetics ; Clustered Regularly Interspaced Short Palindromic Repeats ; DNA ; Trichomonas Infections ; Escherichia coli
    Chemische Substanzen DNA (9007-49-2)
    Sprache Englisch
    Erscheinungsdatum 2024-01-08
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2409480-8
    ISSN 1756-3305 ; 1756-3305
    ISSN (online) 1756-3305
    ISSN 1756-3305
    DOI 10.1186/s13071-023-06106-3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: CRISPR-Cas system: from diagnostic tool to potential antiviral treatment.

    Rajan, Aishwarya / Shrivastava, Stuti / Janhawi / Kumar, Akhilesh / Singh, Alok Kumar / Arora, Pankaj Kumar

    Applied microbiology and biotechnology

    2022  Band 106, Heft 18, Seite(n) 5863–5877

    Abstract: ... technology is being applied to diagnose infectious and non-infectious diseases. • A new generation of CRISPR ... of diseases. • Crispr-Cas tools can be used to combat viral infections, specifically HIV, influenza, and SARS ... This mini review focuses on the diagnosis and treatment of virus diseases using Crisper-Cas ...

    Abstract This mini review focuses on the diagnosis and treatment of virus diseases using Crisper-Cas technology. The present paper describes various strategies involved in diagnosing diseases using Crispr-Cas-based assays. Additionally, CRISPR-Cas systems offer great potential as new therapeutic tools for treating viral infections including HIV, Influenza, and SARS-CoV-2. There are several major challenges to be overcome before this technology can be applied routinely in clinical settings, such as finding a suitable delivery tool, toxicity, and immunogenicity, as well as off-target effects. This review also discusses ways to deal with the challenges associated with Crisper-Cas technology. KEY POINTS: • Crisper technology is being applied to diagnose infectious and non-infectious diseases. • A new generation of CRISPR-Cas-based assays has been developed which detect pathogens within minutes, providing rapid diagnosis of diseases. • Crispr-Cas tools can be used to combat viral infections, specifically HIV, influenza, and SARS-CoV-2.
    Mesh-Begriff(e) Antiviral Agents/therapeutic use ; COVID-19/diagnosis ; COVID-19 Testing ; CRISPR-Cas Systems ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; Humans ; Influenza, Human/diagnosis ; Influenza, Human/drug therapy ; SARS-CoV-2/genetics ; Virus Diseases/diagnosis ; Virus Diseases/drug therapy ; COVID-19 Drug Treatment
    Chemische Substanzen Antiviral Agents
    Sprache Englisch
    Erscheinungsdatum 2022-08-26
    Erscheinungsland Germany
    Dokumenttyp Journal Article ; Review
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-022-12135-2
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: CRISPR-ENHANCE: An enhanced nucleic acid detection platform using Cas12a.

    Nguyen, Long T / Gurijala, Jeevan / Rananaware, Santosh R / Pizzano, Brianna L M / Stone, Brandon T / Jain, Piyush K

    Methods (San Diego, Calif.)

    2021  Band 203, Seite(n) 116–124

    Abstract: ... and non-infectious diseases. CRISPR-based diagnostic platforms are well-established for rapid and ... LAMP-based target amplification step to enable detection of RNA, ssDNA and dsDNA. Furthermore ... a protocol for in-house expression and purification of LbCas12a using CL7/lm7-based affinity chromatography ...

    Abstract Rapid detection of nucleic acids is essential for clinical diagnosis of a wide range of infectious and non-infectious diseases. CRISPR-based diagnostic platforms are well-established for rapid and specific detection of nucleic acids but suffer from a low detection sensitivity without a target pre-amplification step. Our recently developed detection system, called CRISPR-ENHANCE, employs engineered crRNAs and optimized conditions to achieve a significantly higher sensitivity and enable femtomolar levels of nucleic acid detection even without target pre-amplification. Using the CRISPR-ENHANCE platform and following the methodology detailed in this paper, nucleic acid detection for low copy numbers can be achieved in less than an hour through either a fluorescence-based detection or a lateral flow assay. The step-by-step instructions provided, in addition to describing how to perform both assays, incorporate details on a LAMP/RT-LAMP-based target amplification step to enable detection of RNA, ssDNA and dsDNA. Furthermore, a protocol for in-house expression and purification of LbCas12a using CL7/lm7-based affinity chromatography, which has been used to achieve a high yield and purity of the enzyme in a single-step, is provided.
    Mesh-Begriff(e) CRISPR-Cas Systems/genetics ; DNA, Single-Stranded/genetics ; Nucleic Acid Amplification Techniques/methods ; Nucleic Acids ; SARS-CoV-2
    Chemische Substanzen DNA, Single-Stranded ; Nucleic Acids
    Sprache Englisch
    Erscheinungsdatum 2021-02-09
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1066584-5
    ISSN 1095-9130 ; 1046-2023
    ISSN (online) 1095-9130
    ISSN 1046-2023
    DOI 10.1016/j.ymeth.2021.02.001
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel: CRISPR-Cas system: from diagnostic tool to potential antiviral treatment

    Rajan, Aishwarya / Shrivastava, Stuti / Janhawi / Kumar, Akhilesh / Singh, Alok Kumar / Arora, Pankaj Kumar

    Applied microbiology and biotechnology. 2022 Sept., v. 106, no. 18

    2022  

    Abstract: ... technology is being applied to diagnose infectious and non-infectious diseases. • A new generation of CRISPR ... of diseases. • Crispr-Cas tools can be used to combat viral infections, specifically HIV, influenza, and SARS ... This mini review focuses on the diagnosis and treatment of virus diseases using Crisper-Cas ...

    Abstract This mini review focuses on the diagnosis and treatment of virus diseases using Crisper-Cas technology. The present paper describes various strategies involved in diagnosing diseases using Crispr-Cas-based assays. Additionally, CRISPR-Cas systems offer great potential as new therapeutic tools for treating viral infections including HIV, Influenza, and SARS-CoV-2. There are several major challenges to be overcome before this technology can be applied routinely in clinical settings, such as finding a suitable delivery tool, toxicity, and immunogenicity, as well as off-target effects. This review also discusses ways to deal with the challenges associated with Crisper-Cas technology. KEY POINTS: • Crisper technology is being applied to diagnose infectious and non-infectious diseases. • A new generation of CRISPR-Cas-based assays has been developed which detect pathogens within minutes, providing rapid diagnosis of diseases. • Crispr-Cas tools can be used to combat viral infections, specifically HIV, influenza, and SARS-CoV-2.
    Schlagwörter CRISPR-Cas systems ; Severe acute respiratory syndrome coronavirus 2 ; biotechnology ; diagnostic techniques ; immunogenicity ; influenza ; toxicity ; viruses
    Sprache Englisch
    Erscheinungsverlauf 2022-09
    Umfang p. 5863-5877.
    Erscheinungsort Springer Berlin Heidelberg
    Dokumenttyp Artikel
    Anmerkung Review
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-022-12135-2
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  9. Artikel: CRISPR-ENHANCE: An enhanced nucleic acid detection platform using Cas12a

    Nguyen, Long T. / Gurijala, Jeevan / Rananaware, Santosh R. / Pizzano, Brianna L.M. / Stone, Brandon T. / Jain, Piyush K.

    Methods. 2021 Feb. 01,

    2021  

    Abstract: ... and non-infectious diseases. CRISPR-based diagnostic platforms are well-established for rapid and ... LAMP-based target amplification step to enable detection of RNA, ssDNA and dsDNA. Furthermore ... a protocol for in-house expression and purification of LbCas12a using CL7/lm7-based affinity chromatography ...

    Abstract Rapid detection of nucleic acids is essential for clinical diagnosis of a wide range of infectious and non-infectious diseases. CRISPR-based diagnostic platforms are well-established for rapid and specific detection of nucleic acids but suffer from a low detection sensitivity without a target pre-amplification step. Our recently developed detection system, called CRISPR-ENHANCE, employs engineered crRNAs and optimized conditions to achieve a significantly higher sensitivity and enable femtomolar levels of nucleic acid detection even without target pre-amplification. Using the CRISPR-ENHANCE platform and following the methodology detailed in this paper, nucleic acid detection for low copy numbers can be achieved in less than an hour through either a fluorescence-based detection or a lateral flow assay. The step-by-step instructions provided, in addition to describing how to perform both assays, incorporate details on a LAMP/RT-LAMP-based target amplification step to enable detection of RNA, ssDNA and dsDNA. Furthermore, a protocol for in-house expression and purification of LbCas12a using CL7/lm7-based affinity chromatography, which has been used to achieve a high yield and purity of the enzyme in a single-step, is provided.
    Schlagwörter RNA ; affinity chromatography ; detection limit ; enzymes ; rapid methods
    Sprache Englisch
    Erscheinungsverlauf 2021-0201
    Erscheinungsort Elsevier Inc.
    Dokumenttyp Artikel
    Anmerkung Pre-press version
    ZDB-ID 1066584-5
    ISSN 1095-9130 ; 1046-2023
    ISSN (online) 1095-9130
    ISSN 1046-2023
    DOI 10.1016/j.ymeth.2021.02.001
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Correction to

    Somayeh Jolany vangah / Camellia Katalani / Hannah A. Boone / Abbas Hajizade / Adna Sijercic / Gholamreza Ahmadian

    Biological Procedures Online, Vol 22, Iss 1, Pp 1-

    CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases

    2020  Band 1

    Abstract: An amendment to this paper has been published and can be accessed via the original article. ...

    Abstract An amendment to this paper has been published and can be accessed via the original article.
    Schlagwörter Medicine (General) ; R5-920 ; Biology (General) ; QH301-705.5
    Sprache Englisch
    Erscheinungsdatum 2020-11-01T00:00:00Z
    Verlag BMC
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang